Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19787931 | 0.93 | ALDH1A1 (0.56) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL1425164 | 0.91 | ALDH1A1 (0.54) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL3909018 | 0.88 | ALDH1A1 (0.51) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL3094672 | 0.88 | ALDH1A1 (0.51) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL13995281 | 0.87 | CYP1A2 (0.49) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL3008182 | 0.87 | ALDH1A1 (0.50) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL22854579 | 0.87 | ALDH1A1 (0.50) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL3093655 | 0.85 | ALDH1A1 (0.49) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL3095634 | 0.84 | ALDH1A1 (0.48) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 | |
| SCHEMBL862340 | 0.84 | CYP1A2 (0.66) | CYP1A2ALDH1A1SMN1; SMN2POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118724918-A | Pyridine aromatic amide luminescent macrocyclic compound and preparation method and application thereof | 广东工业大学 | 2024-10-01 | — | — | CN | claimed |
| WO-2023129040-A2 | A NEW PHOSPHOPEPTIDE ENRICHMENT MATERIAL CONTAINING MAGNETIC NANOPARTICLES AND A PRODUCTION METHOD THEREOF | AKDENIZ UNIVERSITESI (TR) | 2023-07-06 | — | — | WO | claimed |
| CN-118724918-A | Pyridine aromatic amide luminescent macrocyclic compound and preparation method and application thereof | 广东工业大学 | 2024-10-01 | — | — | CN | disclosed |
| WO-2023129040-A2 | A NEW PHOSPHOPEPTIDE ENRICHMENT MATERIAL CONTAINING MAGNETIC NANOPARTICLES AND A PRODUCTION METHOD THEREOF | AKDENIZ UNIVERSITESI (TR) | 2023-07-06 | — | — | WO | disclosed |
| US-9873693-B2 | Methods of treatment using pyridinonyl PDK1 inhibitors | SUNESIS PHARMACEUTICALS, INC. (US) | 2018-01-23 | — | — | US | disclosed |
| EP-2195310-B1 | LUMINESCENT LANTHANIDE (III) CHELATES, CHELATING AGENTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2016-06-01 | — | — | EP | disclosed |
| WO-2014147288-A1 | LUMINESCENT TRIAZACYCLONONANE-BASED LANTHANIDE CHELATE COMPLEXES AS LABELLING REAGENTS | KAIVOGEN OY (FI) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014147288-A1 | LUMINESCENT TRIAZACYCLONONANE-BASED LANTHANIDE CHELATE COMPLEXES AS LABELLING REAGENTS | KAIVOGEN OY (FI) | 2014-09-25 | — | — | WO | disclosed |
| US-8778977-B2 | Pyridinonyl PDK1 inhibitors | SUNESIS PHARMACEUTICALS, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| US-8778977-B2 | Pyridinonyl PDK1 inhibitors | SUNESIS PHARMACEUTICALS, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| US-8221719-B2 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof | WALLAC OY (FI) | 2012-07-17 | — | — | US | disclosed |
| US-6077954-A | COMPOUNDS ARE CONSTRUCTED TO INCLUDE A CENTRAL AROMATIC, ALIPHATIC, OR HETEROCYCLIC RING SYSTEM. ATTACHED TO THE CENTRAL RING SYSTEM ARE TWO LINEAR GROUPS HAVING NITROGENOUS MOIETIES THAT ARE DERIVATIZED WITH CHEMICAL FUNCTIONAL GROUPS. | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-20 | — | — | US | disclosed |
| WO-1999011612-A2 | SUBSTITUTED CYCLIC COMPOUNDS AND MIXTURES COMPRISING SAME | ISIS PHARMACEUTICALS, INC. (US) | 1999-03-11 | — | — | WO | disclosed |
| US-5780241-A | ALTERING ELECTROCHEMICAL PROPERTIES BY DECYCLIZATION | ISIS PHARMACEUTICALS, INC. (US) | 1998-07-14 | — | — | US | disclosed |
| WO-1998020349-A1 | COMPLEX CHEMICAL LIBRARIES | ISIS PHARMACEUTICALS, INC. (US) | 1998-05-14 | — | — | WO | disclosed |
| WO-1998005961-A1 | COMPOUNDS HAVING A PLURALITY OF NITROGENOUS SUBSTITUENTS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0817787-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030377-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| US-5457186-A | Immunoassay | WALLAC OY (FI) | 1995-10-10 | — | — | US | disclosed |
| EP-0649020-A1 | Luminescent lanthanide chelates with decreased non-radiative energy loss | WALLAC OY (FI) | 1995-04-19 | — | — | EP | disclosed |